StockData
AbbVie Inc. logo

AbbVie Inc. (ABBV) stock

ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/3090% above fair value
$292.82−1.73 (-0.59%)

Close on Nov 17, 2026Market cap $517.45BP/E 82.7Yield 2.27%

AbbVie EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

AbbVie's EPS for the twelve months ending Jun 30, 2026 was $3.54, up 68.6% year over year. For fiscal 2025 it was $2.36, down 1.3% from the year before. Over ten years it grew -2.8% a year on average. The highest annual figure on record is $6.63 in fiscal 2022.

Annual eps

PeriodPeriod endValueChange
FY2025Dec 31, 2025$2.36-1.3%
FY2024Dec 31, 2024$2.39-12.1%
FY2023Dec 31, 2023$2.72-59.0%
FY2022Dec 31, 2022$6.63+2.8%
FY2021Dec 31, 2021$6.45+137.1%
FY2020Dec 31, 2020$2.72-48.5%
FY2019Dec 31, 2019$5.28+44.3%
FY2018Dec 31, 2018$3.66+10.9%
FY2017Dec 31, 2017$3.30-9.1%
FY2016Dec 31, 2016$3.63+16.0%
FY2015Dec 31, 2015$3.13+184.5%
FY2014Dec 31, 2014$1.10-57.0%
FY2013Dec 31, 2013$2.56-23.6%
FY2012Dec 31, 2012$3.35+53.7%
FY2011Dec 31, 2011$2.18–

Quarterly eps

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$2.03+290.4%
Q1 FY2026Mar 31, 2026$0.39-45.8%
Q4 FY2025Dec 31, 2025$1.02–
Q3 FY2025Sep 30, 2025$0.10-88.6%
Q2 FY2025Jun 30, 2025$0.52-32.5%
Q1 FY2025Mar 31, 2025$0.72-6.5%
Q4 FY2024Dec 31, 2024-$0.02-104.3%
Q3 FY2024Sep 30, 2024$0.88-12.0%
Q2 FY2024Jun 30, 2024$0.77-32.5%
Q1 FY2024Mar 31, 2024$0.77+492.3%
Q4 FY2023Dec 31, 2023$0.46-66.7%
Q3 FY2023Sep 30, 2023$1.00-54.8%
Q2 FY2023Jun 30, 2023$1.14+123.5%
Q1 FY2023Mar 31, 2023$0.13-94.8%
Q4 FY2022Dec 31, 2022$1.38-38.9%
Q3 FY2022Sep 30, 2022$2.21+24.2%
Q2 FY2022Jun 30, 2022$0.51+21.4%
Q1 FY2022Mar 31, 2022$2.51+26.1%
Q4 FY2021Dec 31, 2021$2.26+22500.0%
Q3 FY2021Sep 30, 2021$1.78+38.0%
Q2 FY2021Jun 30, 2021$0.42–
Q1 FY2021Mar 31, 2021$1.99-1.5%
Q4 FY2020Dec 31, 2020$0.01-99.5%
Q3 FY2020Sep 30, 2020$1.29+2.4%
Q2 FY2020Jun 30, 2020-$0.46-193.9%
Q1 FY2020Mar 31, 2020$2.02+22.4%
Q4 FY2019Dec 31, 2019$1.88–
Q3 FY2019Sep 30, 2019$1.26-30.4%
Q2 FY2019Jun 30, 2019$0.49-61.1%
Q1 FY2019Mar 31, 2019$1.65-5.2%
Q4 FY2018Dec 31, 2018-$1.23-4200.0%
Q3 FY2018Sep 30, 2018$1.81+79.2%
Q2 FY2018Jun 30, 2018$1.26+5.9%
Q1 FY2018Mar 31, 2018$1.74+64.2%
Q4 FY2017Dec 31, 2017$0.03-96.5%
Q3 FY2017Sep 30, 2017$1.01+4.1%
Q2 FY2017Jun 30, 2017$1.19–
Q1 FY2017Mar 31, 2017$1.06–
Q4 FY2016Dec 31, 2016$0.85–
Q3 FY2016Sep 30, 2016$0.97–

More AbbVie figures

See a number that looks wrong?